TMS was selected as a finalist of the Citeline Pharma Intelligence Awards Japan 2023
  • Sep 07, 2023
サブ-ナビゲーション
  • TMS Co., Ltd.
  • Pipeline
  • Investor Relations
    • 現在位置:News Releases
    • Events
    • IR Library
    • Financial Information
    • Stock Information
    • Corporate Governance
    • Frequently Asked Questions
    • Management Policy
    • Disclosure Policy
    • Disclaimer
    • Contact
  • News
  • About Us
  • Business
  • Contact
  • Privacy Policy

TMS was selected as a finalist of the Citeline Pharma Intelligence Awards Japan 2023

  • Sep 07, 2023
  • About Us
  • Letter from CEO
  • Our Mission
  • Company Info
  • Management Team
  • Board of Directors
  • History

About Us

  • Business
  • Pipeline
  • Science
  • Business Model

Business

Pipeline

  • Investor Relations
  • News Releases
  • Events
  • IR Library
  • Financial Information
  • Stock Information
  • Corporate Governance
  • Frequently Asked Questions
  • Management Policy
  • Disclosure Policy
  • Disclaimer
  • Contact

Investor Relations

News

  • JP
  • EN
  • navi-3way
  • JP
  • EN

ページの先頭へ
ページの先頭へ
  • CLOSE
  • MENU

サイト内検索

Cookie Policy

We use cookies to provide you with a better browsing experience.
Please confirm that you agree to our use of cookies by clicking Yes.
If you continue to browse this website even without agreeing to our use of cookies,
we consider that you have consented to our use of cookies.

Yes

About Us

  • Letter from CEO
  • Our Mission
  • Company Info
  • Management Team
  • Board of Directors
  • History

Business

  • Pipeline
  • Science
  • Business Model

Pipeline

  • Pipeline
  • TMS-007
  • TMS-008
  • TMS-010

IR

  • News Releases
  • Events
  • IR Library
  • Financial Information
  • Stock Information
  • Corporate Governance
  • Frequently Asked Questions
  • Management Policy
  • Disclosure Policy
  • Disclaimer
  • Contact

News

  • Contact
  • Privacy Policy

© 2021 TMS Co., Ltd.